Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Ardent Health, Inc. (ARDT : NYSE)
 
 • Company Description   
Ardent Health Partners Inc. is a provider of healthcare. Ardent Health Partners Inc., formerly known as ARDENT HEALTH, is based in BRENTWOOD, Tenn.

Number of Employees: 25,200

 
 • Price / Volume Information   
Yesterday's Closing Price: $10.64 Daily Weekly Monthly
20 Day Moving Average: 505,420 shares
Shares Outstanding: 143.35 (millions)
Market Capitalization: $1,525.24 (millions)
Beta: 0.76
52 Week High: $15.48
52 Week Low: $7.71
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 9.35% 8.50%
12 Week 4.83% 2.26%
Year To Date 20.50% 11.29%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
340 SEVEN SPRINGS WAY SUITE 100
-
BRENTWOOD,TN 37027
USA		 ph: 615-296-3000
fax: -		 investor.relations@ardenthealth.com http://www.ardenthealth.com
 
 • General Corporate Information   
Officers
Martin J. Bonick - President and Chief Executive Officer; Director
Alfred Lumsdaine - Chief Financial Officer
David Byers - Senior Vice President
Mark Sotir - Director
Peter Bulgarelli - Director

Peer Information
Ardent Health, Inc. (CHCR)
Ardent Health, Inc. (ESRX)
Ardent Health, Inc. (MYDP)
Ardent Health, Inc. (COR)
Ardent Health, Inc. (GBCS)
Ardent Health, Inc. (LAXAF)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: Medical Services
Sector: Medical
CUSIP: 03980N107
SIC: 8062
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/26
Next Expected EPS Date: 08/04/26
Share - Related Items
Shares Outstanding: 143.35
Most Recent Split Date: (:1)
Beta: 0.76
Market Capitalization: $1,525.24 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $0.24 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $1.06 Payout Ratio: 0.00
Number of Estimates in the Fiscal Year Consensus: 3.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: 4.00% Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/04/26  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 10.01
Trailing 12 Months: 6.49
PEG Ratio: 2.50
Price Ratios
Price/Book: 0.88
Price/Cash Flow: 3.87
Price / Sales: 0.24
EPS Growth
vs. Year Ago Period: -3.45%
vs. Previous Quarter: -12.50%
Sales Growth
vs. Year Ago Period: 6.99%
vs. Previous Quarter: -0.20%
ROE
06/30/26 - -
03/31/26 - 13.85
12/31/25 - 14.30
ROA
06/30/26 - -
03/31/26 - 4.48
12/31/25 - 4.58
Current Ratio
06/30/26 - -
03/31/26 - 2.12
12/31/25 - 1.97
Quick Ratio
06/30/26 - -
03/31/26 - 2.00
12/31/25 - 1.85
Operating Margin
06/30/26 - -
03/31/26 - 3.61
12/31/25 - 3.69
Net Margin
06/30/26 - -
03/31/26 - 2.09
12/31/25 - 2.15
Pre-Tax Margin
06/30/26 - -
03/31/26 - 4.46
12/31/25 - 4.53
Book Value
06/30/26 - -
03/31/26 - 12.12
12/31/25 - 11.78
Inventory Turnover
06/30/26 - -
03/31/26 - 0.00
12/31/25 - 0.00
Debt-to-Equity
06/30/26 - -
03/31/26 - 0.62
12/31/25 - 0.64
Debt-to-Capital
06/30/26 - -
03/31/26 - 38.12
12/31/25 - 38.92
 

Powered by Zacks Investment Research ©